Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 higher-dose study of S-888711 in thrombocytopenic patients with chronic liver disease
jRCT2080221585Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of lusutrombopag in Thrombocytopenia and chronic liver disease (CLD), sponsored by Shionogi & Co., Ltd.
02
Drugs
lusutrombopag
03
Conditions
Thrombocytopeniachronic liver disease (CLD)
Beyond the preview
Go deeper on jRCT2080221585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221585.